Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-24

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features [NA]

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of ExAblate Subthalomotomy for motor features of Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ExAblate Subthalomotomy

Snippet

Sponsor: InSightec | Conditions: Parkinson Disease | NA | Status: COMPLETED